These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 15670841

  • 21. Assessment of the bioactivity of antibodies against beta-amyloid peptide in vitro and in vivo.
    Mohajeri MH, Gaugler MN, Martinez J, Tracy J, Li H, Crameri A, Kuehnle K, Wollmer MA, Nitsch RM.
    Neurodegener Dis; 2004; 1(4-5):160-7. PubMed ID: 16908985
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Amyloid-beta immunotherapies in mice and men.
    Brendza RP, Holtzman DM.
    Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Immunologic tolerance of anti-Abeta antibody in the sera of AD patients].
    Yang ZY, Wang HQ, Xu J, Xie Y, Yuan QF, Yao ZB.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):929-31. PubMed ID: 17908502
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME, Gouras G, Relkin NR, Szabo P.
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
    Seabrook TJ, Thomas K, Jiang L, Bloom J, Spooner E, Maier M, Bitan G, Lemere CA.
    Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B, Rangel M, Hunter Z, Peabody DS.
    Vaccine; 2006 Sep 11; 24(37-39):6321-31. PubMed ID: 16806604
    [Abstract] [Full Text] [Related]

  • 35. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
    Okura Y, Miyakoshi A, Kohyama K, Park IK, Staufenbiel M, Matsumoto Y.
    Proc Natl Acad Sci U S A; 2006 Jun 20; 103(25):9619-24. PubMed ID: 16769900
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Species-specific immune response to immunization with human versus rodent A beta peptide.
    Seabrook TJ, Bloom JK, Iglesias M, Spooner ET, Walsh DM, Lemere CA.
    Neurobiol Aging; 2004 Oct 20; 25(9):1141-51. PubMed ID: 15312960
    [Abstract] [Full Text] [Related]

  • 40. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.
    Hock C, Konietzko U, Papassotiropoulos A, Wollmer A, Streffer J, von Rotz RC, Davey G, Moritz E, Nitsch RM.
    Nat Med; 2002 Nov 20; 8(11):1270-5. PubMed ID: 12379846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.